Status:
UNKNOWN
Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity
Lead Sponsor:
Bandim Health Project
Conditions:
Mortality
Morbidity
Eligibility:
All Genders
6-5 years
Phase:
PHASE4
Brief Summary
Vitamin A supplementation (VAS) is important for the immune system and may interact with different childhood vaccinations. We have hypothesized that the improved survival after VAS may depend on vitam...
Detailed Description
Vitamin A supplementation (VAS) acts as an adjuvant to vaccines, and VAS has been shown to enhance both cellular and humoral immune responses in animals and in humans. Routine childhood vaccinations h...
Eligibility Criteria
Inclusion
- Between 6 months and 5 years and thus eligible for vitamin A and missing vaccines during national immunisation days -
Exclusion
- Overt signs of vitamin A deficiency
- \-
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2014
Estimated Enrollment :
6200 Patients enrolled
Trial Details
Trial ID
NCT00168623
Start Date
November 1 2003
End Date
December 1 2014
Last Update
November 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau